Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.
Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedSeveral links related to rare diseases and clinical trials have been removed, including those for renal cell carcinoma and various treatment options, while no new content has been added.SummaryDifference3%
- Check41 days agoChange DetectedThe website has added several new resources related to renal cell carcinoma treatments, including links to clinical trial information and drug labels for Ipilimumab, Cabozantinib, and Nivolumab, while updating to version 2.12.2.SummaryDifference4%
- Check55 days agoChange DetectedThe website has been updated to include the latest completed entries and a new revision (v2.12.1), while removing outdated information and the previous revision (v2.12.0).SummaryDifference0.9%
- Check63 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.